Health Care: Drugs

Regulus Therapeutics Inc (RGLS: NASDAQ)

$1.1 0.12 | 12.24%
07/24/17 - 04:00 PM ET
Company Profile
Price and Volume
Recent Price 0.98
52 Week High 4.25
52 Week Low 0.86
Avg. Daily Vol. (Mil) 0.81
Beta (3 year) 1.63
Share Related Items
Mkt Cap (Mil) 52.12
Shares Out (Mil) 53.18
Float (Mil) 44.17
Dividend Information
Yield % 0.00
Annual Dividend 0.00
Payout Ratio 0.00
Financial Strength
Quick Ratio 5.50
Current Ratio 6.40
LT Debt/ Equity 0.51
Total Debt / Equity 0.51
Valuation Ratios
Price Earnings n.a.
Price/Sales 72.09
Price/Book 1.35
Price/Cash Flow -0.70
Per Share Data
Earnings -1.53
Sales 0.01
Book Value 0.73
Cash Flow -1.46
Business Summary
Regulus Therapeutics Inc is a biotechnology company that focuses on the development of microRNA therapies. MicroRNA is a noncoding ribonucleic acid that regulates most genes in the genome.
General Information
10614 Science Center Drive
San Diego, CA 92121
Industry : Drugs
Sector: Health Care
Employees: 92
CEO: Mr. Joseph P. Hagan
Short Interest
Current Month (Mil) 2.42
Previous Month (Mil) 4.28
Short Interest Ratio (Days) 3.20
Management Effectiveness
Return on Equity n.a.
Return on Assets -100.60
Return on Investments -137.80
Gross Margin n.a.
EBIT Margin n.a.
Profit Margin 0.00

Portfolios with RGLS

Latest RGLS Headlines from TheStreet

More Financial News for RGLS

Press Releases for RGLS

See All Press Releases

Partner Headlines for RGLS

brokerage partners
watch thestreet tv
No Videos Found
connect with Stockpickr
Fan us on FaceBook
Follow us on Twitter